Skip to content

Assessment of the effect of topical calcitriol on Chronic Rhinosinusitis

Assessment of the effect of topical calcitriol on Chronic Rhinosinusitis with and without polyps

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201705173186N11
Enrollment
60
Registered
2017-10-20
Start date
2017-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic rhinosinusitis with and without polyps. chronic sinusitis

Interventions

Intervention 1: Intervention group: nasal spray fluticasone once a day, 2 puff in each nasal cavity with calcitriol spray once a day (equivalent 2000 unit vitamin D or 50 micro gram calcitriol) for on
Treatment - Drugs
Intervention group: nasal spray fluticasone once a day, 2 puff in each nasal cavity with calcitriol spray once a day (equivalent 2000 unit vitamin D or 50 micro gram calcitriol) for one month
control group: nasal spray fluicasone and placebo

Sponsors

Vice chancellor for research, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all patients older than 18 years with the diagnostic criteria for chronic rhinosinusitis with polyposis based on the EPOS 2012 criteria. Exclusion criteria: smoking; sensitivity to vitamin D3; pregnancy; use of systemic steroids in last month; immunosuppressive drugs; history of any endocrine disease, malignancy, acute rhinosinisitis during study, surgery for rhinosinusitis, complication of rhinosinusitis, calcification of soft tissue and hypercalcemia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Chronic rhinosinusitis. Timepoint: Before intervention and 1and 3 months after intervention. Method of measurement: VAS, SNOT22 and Lund Kennedy scoring.

Secondary

MeasureTime frame
Drug adverse effect such as nasal irritation. Timepoint: during study period. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnaz Hashemian

Hamadan University of Medical Sciences

hashemian@umsha.ac.ir- farnazhashemian@yahoo.com+98 81 3264 0047

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026